RALLYBIO CORP - DISCONTINUES RLYB212 PROGRAM FOR PREVENTION OF FNAIT
RALLYBIO CORP: RLYB212 PHASE 2 PK RESULTS DID NOT ACHIEVE TARGET CONCENTRATIONS
RALLYBIO CORP - TO INITIATE RLYB116 PK/PD STUDY IN 2Q 2025
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.